Market Overview

Goldman Sachs Reiterates Buy Rating, $110 PT on Monsanto Company

Share:
Related MON
3 Niche ETFs Breaking Out
Top 4 NYSE Stocks In The Agricultural Chemicals Industry With The Highest ROI
Monsanto Stands To Gain From Ukraine Crisis (Seeking Alpha)

In a report published Friday, Goldman Sachs Group reiterated its Buy rating and $110.00 price target on Monsanto Company (NYSE: MON).

Goldman Sachs noted, “The strong relative product performance coupled with ongoing commercial ramp for its higher margin reduced refuge corn and RR2 soybean, elevated crop prices and some recent pricing momentum for glyphosate suggest another strong earnings year and market share gains for FY2013. Investors will also take comfort from the positive developments regarding the Department of Justice's formal investigation, the rejection of Prop 37 in California and some progress on Brazilian RR1 patent issues. MON offers attractive EPS growth with limited impact from fiscal cliffs, Chinese leadership changes and European economic malaise. We anticipate another rewarding year of ‘beat and raise' earnings results and reiterate our CL-Buy designation on MON.”

Monsanto Company closed on Thursday at $89.97.

Latest Ratings for MON

DateFirmActionFromTo
Jan 2015CitigroupMaintainsBuy
Jan 2015Deutsche BankMaintainsBuy
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Goldman Sachs GroupAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MON)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→